Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

CRB acquires rights to parallel assembly method from MRC
October 2013
SHARING OPTIONS:

BILLINGHAM, United KingdomóCambridge Research Biochemicals (CRB) has announced that it has licensed the rights to a novel, patentable method of parallel assembly of several peptide-therapeutic cargo combinations. The company intends to launch a service in October to offer custom-made libraries of peptide-cargo conjugates to help speed development and delivery of new therapeutics. This method was developed at the Medical Research Council's Laboratory of Molecular Biology, and was licensed to CRB by MRC Technology on the MRC's behalf. No financial terms were disclosed. Emily Humphrys, commercial director at CRB, noted that the company "enjoys a longstanding relationship with the MRC-LMB both from the formation of the company in 1980 to the ongoing supply contract for peptides and antibodies in place since 2010. This collaboration marks another accolade from the partnership."    

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.